Internal Medicine, Pulmonary Disease · Denison, TX
NPI
1295876399
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
5012 US Hwy 75 Ste 200
Denison, TX, 75020
Phone (903) 465-5012
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
54,842 services
Medicare patients, 2024
1,373
Average age 73
Drug cost, 2024
$10.4M
5,852 prescriptions
Company payments, 2025
$29K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sanober Kable was code J2357 (injection, omalizumab, 5 mg), 20,400 times for 29 patients. In total Sanober Kable billed 54,842 services in 55 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 20,400 | 29 | $29.77 | $607K |
| J2356 Injection, tezepelumab-ekko, 1 mg | Office | 13,651 | 11 | $14.22 | $194K |
| J2182 Injection, mepolizumab, 1 mg | Office | 10,501 | 16 | $23.81 | $250K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,746 | 14 | $0.11 | $184 |
| J0517 Injection, benralizumab, 1 mg | Office | 1,590 | 13 | $130.86 | $208K |
| 99214 Office E&M - Established | Office | 1,337 | 738 | $87.85 | $117K |
| 96372 Injection Administration | Office | 775 | 96 | $10.31 | $7,990 |
| 94729 Pulmonary Function Testing | Office | 722 | 721 | $38.62 | $28K |
| 94726 Pulmonary Function Testing | Office | 700 | 700 | $37.90 | $27K |
| 94618 Pulmonary Function Testing | Office | 644 | 634 | $22.96 | $15K |
| 94010 Pulmonary Function Testing | Office | 383 | 383 | $19.19 | $7,349 |
| 94060 Pulmonary Function Testing | Office | 356 | 354 | $27.11 | $9,650 |
| 99213 Office E&M - Established | Office | 331 | 218 | $62.43 | $21K |
| 96401 Chemotherapy Administration | Office | 315 | 68 | $51.56 | $16K |
| 99204 Office E&M - New | Office | 146 | 146 | $109.69 | $16K |
By year: 2022 $1.5M for 39,790 services; 2023 $1.6M for 53,097 services; 2024 $1.6M for 54,842 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sanober Kable prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 884 prescriptions and refills. In total Sanober Kable wrote 5,852 Medicare prescriptions that cost $10.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 884 | 1,390 | 311 | $880K |
| Montelukast Sodium Generic | 765 | 1,945 | 310 | $8,851 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 576 | 716 | 292 | $16K |
| Azithromycin Generic | 291 | 682 | 173 | $5,780 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 289 | 481 | 121 | $298K |
| Prednisone Generic | 240 | 459 | 143 | $1,232 |
| Zafirlukast Generic | 196 | 402 | 80 | $24K |
| Opsumit Macitentan | 154 | 154 | 16 | $1.9M |
| Ofev Nintedanib Esylate | 141 | 141 | 27 | $1.9M |
| Adempas Riociguat | 117 | 117 | 15 | $1.5M |
| Mirtazapine Generic | 113 | 167 | 49 | $1,584 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 102 | 158 | 30 | $75K |
| Omeprazole Generic | 101 | 231 | 53 | $1,333 |
| Roflumilast Generic | 90 | 138 | 27 | $9,778 |
| Spiriva Respimat Tiotropium Bromide | 80 | 128 | 35 | $66K |
Brand drugs: - claims; generic drugs: 3,137 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sanober Kable $29K ($29K in general payments such as food, travel and fees) from 34 companies. The largest payer was Genzyme Corporation with $24K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 26 | $24K |
| AstraZeneca Pharmaceuticals LP AZN | 23 | $1,833 |
| GlaxoSmithKline, LLC. GSK | 34 | $419 |
| AOP Health US, LLC | 1 | $342 |
| Jazz Pharmaceuticals Inc. JAZZ | 14 | $272 |
| Insmed, Inc. INSM | 14 | $164 |
| Actelion Pharmaceuticals US, Inc. JNJ | 5 | $143 |
| United Therapeutics Corporation UTHR | 13 | $141 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $119 |
| Axsome Therapeutics, Inc. AXSM | 5 | $117 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.